Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

PHASE4CompletedINTERVENTIONAL
Enrollment

632

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

March 10, 2025

Study Completion Date

June 10, 2025

Conditions
Migraine
Interventions
DRUG

Rimegepant

DB Phase: Rimegepant 75 mg Orally Disintegrating Tablet (ODT)

DRUG

Placebo

DB Phase: matching placebo

DRUG

Rimegepant

OLE Phase: Rimegepant 75 mg ODT in association with each of the first 5 qualifying migraines

Trial Locations (93)

1090

UZ Brussel, Brussels

2600

Danish Headache Center, Glostrup Municipality

2610

GZA Ziekenhuizen, Antwerp

3004

Alfred Hospital, Melbourne

3500

Jessa Ziekenhuis, Hasselt

4420

Cabinet Privé Dr. Simona Sava, Saint-Nicolas

4556

USC Clinical Trials Centre, Sippy Downs

6020

Medical University Innsbruck, Innsbruck

9000

UZ Gent, Ghent

9020

Klinikum Klagenfurt am Wörthersee, Klagenfurt

10003

New York Neurology Associates, New York

10117

Charité Universitätsmedizin Berlin, Neurologische Ambulanz, Kopfschmerzambulanz, Berlin

10461

Montefiore Medical Center, The Bronx

11220

DM Clinical Research - NY, NY, Brooklyn

13005

Timone Hospital, Marseille

14050

Operadora Unidad de Investigación En Salud de Chihuahua, Sa de Cv, Mexico City

20100

Terveystalo Pulssi, Turku

20116

Centro de Investigación Médica de Aguascalientes (CIMA), Aguascalientes

20132

IRCCS Ospedale San Raffaele, Milan

20133

Foundation IRCCS Neurological Institute Carlo Besta, Milan

27100

Fondazione Mondino - Istituto Neurologico Nazionale IRCCS, Pavia

27405

Headache Wellness Center, PC, Greensboro

28046

Hospital Universitario La Paz, Madrid

29621

Synexus Clinical Research US, Inc. - Anderson, Anderson

30328

WR-Mount Vernon Clinical Research, LLC, Sandy Springs

32055

Wr-Msra, Llc, Lake City

32174

Sandhill Research, LLC d/b/a Accel Research Sites Network - Ormond Clinical Research Unit, Ormond Beach

33100

Terveystalo Tampere Rautatienkatu, Tampere

34761

Sensible Healthcare LLC, Ocoee

39008

University Hospital Marqués de Valdecilla, Santander

41013

Virgen del Rocio University Hospital, Seville

41124

AOU Policlinico di Modena, Modena

42055

CHU Saint-Etienne - Hopital Nord, Saint-Etienne

46010

Hospital Clínico Universitario de Valencia, Valencia

48076

DM Clinical Research - Detroit, Southfield

48104

Michigan Headache & Neurological Institute, Ann Arbor

48307

Rochester Medical Group, Rochester Hills

54055

Clinical Research Institute S.C., Tlalnepantla

59037

CHU de Lille - Hôpital Salengro, Lille

63000

CHU Clermont Ferrand - Hopital Gabriel Montpied, Clermont-Ferrand

63304

St Charles Clinical Research, Weldon Spring

65807

Clinvest Research, LLC, Springfield

65929

Kopfschmerzzentrum Frankfurt, Frankfurt

66210

Collective Medical Research, Overland Park

69500

Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer, Bron

70115

DelRicht Research, New Orleans

74370

Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy

75010

Hopital Lariboisiere, Paris

77375

DM Clinical Research, Tomball

77566

Red Star Research, LLC, Lake Jackson

80138

AOU Luigi Vanvitelli, Napoli

90048

Clinical Research Institute, Los Angeles

98007

Northwest Clinical Research Center, Bellevue

06905

Ki Health Partners LLC, dba New England Institute for Clinical Research, Stamford

02131

Boston Clinical Trials, Boston

01752

Community Clinical Research Network Inc, Marlborough

T3M 1M4

University of Calgary South Health Campus, Calgary

L6T 0G1

Aggarwal and Associates Limited, Brampton

G6W 0M5

Clinique Neuro-Lévis, Lévis

G3K 2P8

Alpha Recherche Clinique, Québec

G2J 0C4

ALPHA Recherche Clinique, Québec

DK-6700

University Hospital of Southern Denmark, Esbjerg

DK-8800

Hospitalsenhed Midt, Viborg

00830

Helsinki Headache Center, Helsinki

Unknown

Terveystalo Ruoholahti, Helsinki

06000

CHU Nice Hopital Cimiez, Nice

D-24149

Neurologische Praxis Prof. Dr. Hartmut Gobel, Kiel

07747

University Hospital Jena, Jena

00128

Fondazione Policlinico Campus BioMedico, Rome

00163

Headache and Pain Unit - IRCCS San Raffaele, Rome

CDMX 06700

Clinstile SA de CV, Mexico City

85-163

Centrum Medyczne Neuromed, Bydgoszcz

52-210

MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak, Wroclaw

67-100

Twoja Przychodnia Nowosolskie Centrum Medyczne, Nowa Sól

00-773

Concept Medica, Warsaw

02-739

MICS Centrum Medyczne Damiana Walbrzyska, Warsaw

32-600

Instytut Zdrowia dr Boczarska-Jedynak Sp. z o.o. Sp. k., Oświęcim

40-748

Vita Longa Sp. Z o.o., Katowice

70-784

MICS Centrum Medyczne Szczecin, Szczecin

00-144

Praktyka Lekarska, Warsaw

02-172

MTZ Clinical Research Powered by Pratia, Warsaw

91-363

Centrum Leczenia Bolu dr n med Lukasz Kmieciak, Lodz

08035

Hospital Universitari Vall d'Hebron, Barcelona

171 64

CTC Solna, Solna

752 37

CTC Uppsala, Uppsala

222 22

Skåneuro Privatmottagning, Lund

112 39

Hälsoklustret, Stockholm

117 27

Akardo MedSite, Stockholm

B16 8LT

Re: Cognition Health Ltd., Edgebaston

IG1 4HP

4 Medical Clinical Solutions London, Ilford

NN17 2UR

Lakeside Healthcare Group Research, Corby

WC2R 2LS

Kings College London, London

M27 8FF

4 Medical Clinical Solutions, Swinton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05509400 - Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use | Biotech Hunter | Biotech Hunter